These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 175023)

  • 61. Epstein-Barr virus and human malignancy.
    Ziegler JL; Magrath IT; Gerber P; Levine PH
    Ann Intern Med; 1977 Mar; 86(3):323-36. PubMed ID: 190930
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antibodies to Epstein-Barr virus (EBV) antigens in sera of American Burkitt lymphoma patients.
    Ablashi DV; De-Thé GB; Easton JM; Liabeuf A; Levine PH; Armstrong GR
    Biomedicine; 1974 Jul; 21(7):288-93. PubMed ID: 4139981
    [No Abstract]   [Full Text] [Related]  

  • 63. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
    Fresen KO; zur Hausen H
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Colony morphology, cell growth and viral radiosensitivity as parameters for detecting strain differences in Epstein-Barr virus (EBV).
    Levitt M; Shungu D; Henderson E
    Int J Cancer; 1980 Oct; 26(4):509-15. PubMed ID: 6265384
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sites of Epstein-Barr virus replication in acute and chronic active Epstein-Barr virus infections.
    Kikuta H; Osato T; Matsumoto S
    Intervirology; 1989; 30(6):346-50. PubMed ID: 2559902
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Epstein-Barr virus and the immune system.
    Tosato G
    Adv Cancer Res; 1987; 49():75-125. PubMed ID: 2823544
    [No Abstract]   [Full Text] [Related]  

  • 67. Expression of Epstein-Barr virus-encoded proteins and B-cell markers in fatal infectious mononucleosis.
    Falk K; Ernberg I; Sakthivel R; Davis J; Christensson B; Luka J; Okano M; Grierson HL; Klein G; Purtilo DT
    Int J Cancer; 1990 Dec; 46(6):976-84. PubMed ID: 2174416
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.
    Hochberg D; Middeldorp JM; Catalina M; Sullivan JL; Luzuriaga K; Thorley-Lawson DA
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):239-44. PubMed ID: 14688409
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epstein-Barr virus replication in oropharyngeal epithelial cells.
    Sixbey JW; Nedrud JG; Raab-Traub N; Hanes RA; Pagano JS
    N Engl J Med; 1984 May; 310(19):1225-30. PubMed ID: 6323983
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Relation between Epstein-- Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. II. Comparison of cells and sera from patients with Burkitt's lymphoma and infectious mononucleosis.
    Klein G; Pearson G; Henle G; Henle W; Diehl V; Niederman JC
    J Exp Med; 1968 Nov; 128(5):1021-30. PubMed ID: 4878907
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Epstein-Barr virus markers in a series of Burkitt's lymphomas from the West Nile District, Uganda.
    Geser A; Lenoir GM; Anvret M; Bornkamm G; Klein G; Williams EH; Wright DH; De-The G
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1393-404. PubMed ID: 6315443
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Epstein-Barr virus (EBV): evidence for EBV strains.
    Menezes J; Leibold W; Klein G
    IARC Sci Publ (1971); 1975; (11 Pt 1):323-30. PubMed ID: 190135
    [No Abstract]   [Full Text] [Related]  

  • 74. Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA.
    Clements GB; Klein G; Povey S
    Int J Cancer; 1975 Jul; 16(1):125-33. PubMed ID: 170210
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye.
    Sairenji T; Hinuma Y
    Int J Cancer; 1980 Sep; 26(3):337-42. PubMed ID: 6270005
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Seroepidemiology of Epstein-Barr virus].
    Pannuti CS
    Rev Saude Publica; 1981 Feb; 15(1):93-100. PubMed ID: 6275491
    [No Abstract]   [Full Text] [Related]  

  • 77. Epidemiology of Burkitt's lymphoma: other risk factors.
    Evans AS
    IARC Sci Publ; 1985; (60):197-204. PubMed ID: 2998989
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Leukocyte migration inhibition detects cross-reacting antigens between cells transformed by Epstein-Barr virus (EBV) and EBV-like simian viruses.
    Szigeti R; Rabin H; Timar L; Klein G
    Intervirology; 1986; 26(3):121-8. PubMed ID: 3034820
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epstein-Barr virus infections in childhood.
    Oberender H; Graessner U; Falkenhagen U; Kunkel M; Gärtner L; Kupatz H; Schumacher K
    Acta Virol; 1979 Mar; 23(2):137-42. PubMed ID: 39436
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Specific neutralizing antibodies in Epstein-Barr virus associated diseases.
    Rocchi G; Hewetson J; Henle W
    Int J Cancer; 1973 May; 11(3):637-47. PubMed ID: 4364719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.